Literature DB >> 18475627

Beneficial haemodynamic effect of indomethacin during endotoxin shock in anaesthetized pigsputative involvement of nitric oxide?

T Mózes1, E M Gelderen, E J Mylecharane, P R Saxena.   

Abstract

Endotoxin shock was induced in 31 anaesthetized pigs by infusion of 5 mug/kg of Escbeicbia coli endotoxin (LPS) over 60 min into the superior mesenteric artery. Fifteen of these pigs died within 30 min of the start of LPS infusion whereas the remaining 16 survived the experimental period of 2 h. In a group of nine pigs indomethacin (2 mg/kg, i.v.)was inected 20-25 rain after the start of LPS infusion at which time mean arterial blood pressure (MABP) had decreased below 40 mmHg indicating imminent death. Indomethacin immediately reversed the hypotension. In another group of five pigs, N(G)-nitro L-arginine-methyl ester (L-NAME, 1 and 3 mg/kg)was iniected 10 and 5 min, respectively, before the expected death without any beneficial effect on the hypotension. Three rain after the last dose of L-NAME, indomethacin (2 mg/kg, i.v.) was iniected. In three animals the hypotension was reserved by indomethacin, although this beneficial effect was delayed in comparison with the LP-Streated group not receiving L-NAME. Four pigs were pretreated with L-NAME, 3 mg/kg, i.v., 10 min prior to LPS infusion. All pretreated animals tended to die within 30 min of the start of the LPS infusion. Five rain before the expected death (20-25 rain after the start of LPS infusion) indomethacin (2 mg/kg) was inected. In three of these animals indomethacin reversed hypotenston and prevented death. Interestingly, this rise in the MABP developed very slowly. These results suggest that the beneficial effect of indomethacin in endotoxin shock might be related partially to interference with nitric oxide, which is not the only factor determining blood pressure levels during endotoxic shock.

Entities:  

Year:  1995        PMID: 18475627      PMCID: PMC2365626          DOI: 10.1155/S0962935195000202

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


  25 in total

Review 1.  The proinflammatory cytokines interleukin-1 and tumor necrosis factor and treatment of the septic shock syndrome.

Authors:  C A Dinarello
Journal:  J Infect Dis       Date:  1991-06       Impact factor: 5.226

Review 2.  Endotoxins and disease mechanisms.

Authors:  D C Morrison; J L Ryan
Journal:  Annu Rev Med       Date:  1987       Impact factor: 13.739

3.  Negative inotropic effects of cytokines on the heart mediated by nitric oxide.

Authors:  M S Finkel; C V Oddis; T D Jacob; S C Watkins; B G Hattler; R L Simmons
Journal:  Science       Date:  1992-07-17       Impact factor: 47.728

4.  Regional and cardiac haemodynamic responses to glyceryl trinitrate, acetylcholine, bradykinin and endothelin-1 in conscious rats: effects of NG-nitro-L-arginine methyl ester.

Authors:  S M Gardiner; A M Compton; P A Kemp; T Bennett
Journal:  Br J Pharmacol       Date:  1990-11       Impact factor: 8.739

5.  Involvement of circulating phospholipase A2 in the pathogenesis of the hemodynamic changes in endotoxin shock.

Authors:  P Vadas; J B Hay
Journal:  Can J Physiol Pharmacol       Date:  1983-06       Impact factor: 2.273

6.  Effects of a nitric oxide synthase inhibitor in humans with septic shock.

Authors:  A Petros; G Lamb; A Leone; S Moncada; D Bennett; P Vallance
Journal:  Cardiovasc Res       Date:  1994-01       Impact factor: 10.787

7.  Nitric oxide inhalation attenuates pulmonary hypertension and improves gas exchange in endotoxin shock.

Authors:  E Weitzberg; A Rudehill; J M Lundberg
Journal:  Eur J Pharmacol       Date:  1993-03-16       Impact factor: 4.432

8.  Effects of inhalation and intravenous anesthetic agents on pressor response to NG-nitro-L-arginine.

Authors:  Y X Wang; T Zhou; T C Chua; C C Pang
Journal:  Eur J Pharmacol       Date:  1991-06-06       Impact factor: 4.432

9.  Modes of action of aspirin-like drugs.

Authors:  S Abramson; H Korchak; R Ludewig; H Edelson; K Haines; R I Levin; R Herman; L Rider; S Kimmel; G Weissmann
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

10.  Prostacyclin rather than endogenous nitric oxide is a tissue protective factor in myocardial ischemia.

Authors:  I Woditsch; K Schrör
Journal:  Am J Physiol       Date:  1992-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.